CLGN
CollPlant Biotechnologies Ltd.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Strong sell
-61/100
Last price
3.39
▼ 0.02 (0.59%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
3.41
Day high
3.49
Day low
3.25
Volume
25.02K
Market cap
$6.41M
P/E (TTM)
—
52W range
2.64 – 26.80
Trailing performance
Returnvs SPY
1W
-10.55%
-12.5%
1M
-4.51%
-5.7%
3M
-7.63%
-12.1%
6M
-5.57%
-23.8%
YTD
-75.79%
-90.0%
1Y
-85.87%
-102.3%
3Y
-93.91%
-176.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on CLGN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
484.69K
Total on file
Fundamentals
Market cap$6.41M
Enterprise value$5.00M
Revenue (TTM)$318.00K
Gross profit$-1.02M
EBITDA$-11.56M
Net income$-12.51M
EPS (TTM)$-9.33
Free cash flow$-6.89M
Total cash$2.56M
Total debt$2.66M
Book value / share$2.04
Shares outstanding1.89M
Float869.60K
Short % of float3.47%
Dividend yield0.00%
Beta (5Y)0.76
Valuation & profitability ratios
Trailing P/E—
Forward P/E-8.69
PEG ratio—
Price / sales—
Price / book1.66
EV / revenue15.72
EV / EBITDA-0.43
Gross margin0.00%
Operating margin-2437.96%
Profit margin0.00%
Return on equity-161.98%
Return on assets-62.95%
Debt / equity90.32
Current ratio1.57
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.37M | $515.00K | $10.96M | $299.00K | +360.4% |
| Operating revenue | $2.37M | $515.00K | $10.96M | $299.00K | +360.4% |
| Cost of revenue | $835.00K | $1.63M | $1.99M | $400.00K | -48.6% |
| Gross profit | $1.54M | -$1.11M | $8.97M | -$101.00K | +238.4% |
| Research & development | $8.19M | $10.52M | $10.48M | $10.26M | -22.1% |
| Selling, general & admin | $4.83M | $5.63M | $6.00M | $6.74M | -14.1% |
| Total operating expense | $13.02M | $16.14M | $16.48M | $17.00M | -19.3% |
| Operating income | -$11.48M | -$17.25M | -$7.51M | -$17.10M | +33.4% |
| Net interest income | $365.00K | $721.00K | $778.00K | $287.00K | -49.4% |
| Pre-tax income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | +30.8% |
| Net income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | +30.8% |
| Net income to common | -$11.49M | -$16.61M | -$7.02M | -$16.93M | +30.8% |
| Basic EPS | -0.94 | -1.45 | -0.62 | -1.53 | +35.2% |
| Diluted EPS | -0.94 | -1.45 | -0.62 | -1.53 | +35.2% |
| EBIT | -$11.48M | -$17.25M | -$7.51M | -$17.10M | +33.4% |
| EBITDA | -$10.57M | -$16.21M | -$6.41M | -$16.02M | +34.8% |
| Basic shares | 12.20M | 11.45M | 11.39M | 11.03M | +6.5% |
| Diluted shares | 12.20M | 11.45M | 11.39M | 11.03M | +6.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.59M | $11.91M | $26.67M | $29.65M | -53.1% |
| Cash & short-term investments | $5.59M | $11.91M | $26.67M | $29.65M | -53.1% |
| Accounts receivable | $1.00K | $150.00K | $0 | $9.00K | -99.3% |
| Inventory | $573.00K | $440.00K | $714.00K | $1.43M | +30.2% |
| Total current assets | $6.75M | $13.18M | $28.02M | $31.66M | -48.8% |
| Property, plant & equipment | $3.89M | $5.28M | $5.86M | $5.68M | -26.4% |
| Goodwill & intangibles | $73.00K | $131.00K | $188.00K | $245.00K | -44.3% |
| Total assets | $10.79M | $18.71M | $34.13M | $37.77M | -42.4% |
| Total current liabilities | $2.67M | $2.97M | $3.25M | $3.10M | -10.0% |
| Total debt | $2.85M | $3.08M | $3.16M | $2.91M | -7.6% |
| Total liabilities | $4.70M | $5.25M | $5.79M | $5.49M | -10.3% |
| Retained earnings | -$124.84M | -$113.35M | -$96.74M | -$89.72M | -10.1% |
| Shareholder equity | $6.08M | $13.46M | $28.34M | $32.28M | -54.8% |
| Working capital | $4.08M | $10.21M | $24.77M | $28.55M | -60.1% |
| Net tangible assets | $6.01M | $13.33M | $28.15M | $32.04M | -54.9% |
| Shares issued | 12.82M | 11.47M | 11.47M | 11.19M | +11.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | +30.8% |
| Depreciation & amortisation | $912.00K | $1.04M | $1.10M | $1.08M | -12.1% |
| Stock-based compensation | $999.00K | $1.72M | $1.94M | $2.17M | -41.9% |
| Change in working capital | $254.00K | -$372.00K | $848.00K | -$544.00K | +168.3% |
| Operating cash flow | -$9.42M | -$14.09M | -$2.76M | -$13.70M | +33.2% |
| Capital expenditure | -$28.00K | -$483.00K | -$954.00K | -$1.32M | +94.2% |
| Investing cash flow | -$27.00K | -$539.00K | -$1.16M | $28.92M | +95.0% |
| Financing cash flow | $3.10M | $9.00K | $1.11M | $1.87M | +34,366.7% |
| Free cash flow | -$9.45M | -$14.58M | -$3.72M | -$15.01M | +35.2% |
| End cash position | $5.59M | $11.91M | $26.67M | $29.86M | -53.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $73.00K | $60.00K | $77.00K | $179.00K | $2.06M | +21.7% |
| Operating revenue | $73.00K | $60.00K | $77.00K | $179.00K | $2.06M | +21.7% |
| Cost of revenue | $316.00K | $192.00K | $269.00K | $186.00K | $188.00K | +64.6% |
| Gross profit | -$243.00K | -$132.00K | -$192.00K | -$7.00K | $1.87M | -84.1% |
| Research & development | $1.68M | $1.98M | $2.09M | $2.01M | $2.10M | -15.3% |
| Selling, general & admin | $1.19M | $1.04M | $1.23M | $1.16M | $1.41M | +15.0% |
| Total operating expense | $2.87M | $3.02M | $3.31M | $3.17M | $3.52M | -4.8% |
| Operating income | -$3.12M | -$3.15M | -$3.51M | -$3.18M | -$1.65M | +1.1% |
| Net interest income | $18.00K | $314.00K | $24.00K | -$169.00K | $196.00K | -94.3% |
| Pre-tax income | -$3.10M | -$3.21M | -$3.48M | -$3.35M | -$1.45M | +3.4% |
| Net income | -$3.10M | -$3.21M | -$3.48M | -$3.35M | -$1.45M | +3.4% |
| Net income to common | -$3.10M | -$3.21M | -$3.48M | -$3.35M | -$1.45M | +3.4% |
| Basic EPS | -0.23 | — | -0.27 | -0.28 | -0.13 | — |
| Diluted EPS | -0.23 | — | -0.27 | -0.28 | -0.13 | — |
| EBIT | -$3.12M | -$3.15M | -$3.51M | -$3.18M | -$1.65M | +1.1% |
| EBITDA | -$2.90M | -$2.93M | -$3.28M | -$2.95M | -$1.40M | +1.0% |
| Basic shares | 13.75M | — | 12.72M | 11.84M | 11.45M | — |
| Diluted shares | 13.75M | — | 12.72M | 11.84M | 11.45M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.26M | $5.59M | $8.55M | $11.43M | $10.73M | -23.8% |
| Cash & short-term investments | $4.26M | $5.59M | $8.55M | $11.43M | $10.73M | -23.8% |
| Accounts receivable | $8.00K | $1.00K | $11.00K | $0 | $0 | +700.0% |
| Inventory | $679.00K | $573.00K | $540.00K | $553.00K | $673.00K | +18.5% |
| Total current assets | $5.54M | $6.75M | $9.62M | $12.62M | $12.09M | -17.9% |
| Property, plant & equipment | $3.51M | $3.89M | $4.25M | $4.58M | $4.88M | -9.8% |
| Goodwill & intangibles | $59.00K | $73.00K | $88.00K | $102.00K | $116.00K | -19.2% |
| Total assets | $9.18M | $10.79M | $14.09M | $17.44M | $17.21M | -14.9% |
| Total current liabilities | $2.44M | $2.67M | $2.63M | $2.74M | $2.70M | -8.6% |
| Total debt | $2.65M | $2.85M | $2.94M | $3.03M | $2.84M | -6.9% |
| Total liabilities | $4.30M | $4.70M | $4.78M | $4.93M | $4.81M | -8.7% |
| Retained earnings | -$127.94M | -$124.84M | -$121.63M | -$118.15M | -$114.80M | -2.5% |
| Shareholder equity | $4.89M | $6.08M | $9.30M | $12.51M | $12.40M | -19.7% |
| Working capital | $3.10M | $4.08M | $6.99M | $9.88M | $9.39M | -24.0% |
| Net tangible assets | $4.83M | $6.01M | $9.22M | $12.40M | $12.28M | -19.7% |
| Shares issued | 14.44M | 12.82M | 12.79M | 12.73M | 11.47M | +12.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$3.10M | -$3.21M | -$3.48M | -$3.35M | -$1.45M | +3.4% |
| Depreciation & amortisation | $210.00K | $216.00K | $223.00K | $229.00K | $244.00K | -2.8% |
| Stock-based compensation | $180.00K | -$18.00K | $282.00K | $353.00K | $382.00K | +1,100.0% |
| Change in working capital | -$328.00K | $88.00K | $104.00K | $406.00K | -$344.00K | -472.7% |
| Operating cash flow | -$3.05M | -$2.94M | -$2.88M | -$2.44M | -$1.17M | -3.9% |
| Capital expenditure | -$6.00K | -$15.00K | -$1.00K | -$3.00K | -$9.00K | +60.0% |
| Investing cash flow | -$6.00K | -$15.00K | -$1.00K | -$3.00K | -$8.00K | +60.0% |
| Financing cash flow | $1.72M | $0 | $0 | $3.10M | $0 | — |
| Free cash flow | -$3.06M | -$2.95M | -$2.88M | -$2.44M | -$1.18M | -3.6% |
| End cash position | $4.26M | $5.59M | $8.55M | $11.43M | $10.73M | -23.8% |
Options analytics
Put / call volume
3.50
Put-heavy session
Put / call open interest
0.09
Positioning, not flow
Max pain
2.50
-26.3% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+50.0%
Puts bid over calls
Call volume
2
Contracts, this expiry
Put volume
7
Contracts, this expiry
Heaviest call OI
2.50
224 contracts
Heaviest put OI
7.50
8 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Dec 2025 | -1.90 | -2.50 | -31.6% |
| Sep 2025 | 1.55 | -2.70 | -274.2% |
| Jun 2025 | -1.00 | -2.80 | -180.0% |
| Mar 2025 | -0.40 | -1.30 | -225.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders33.56%
Held by institutions9.93%
Institutions holding17
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.77
-10.03% from price
SMA 20
3.77
-10.04% from price
SMA 50
3.44
-1.53% from price
SMA 100
3.56
-4.67% from price
SMA 200
6.10
-44.44% from price
EMA 12
3.67
-7.72% from price
EMA 26
3.66
-7.35% from price
EMA 50
3.61
-6.11% from price
RSI (14)
43.8
Neutral
MACD (12,26,9)
0.01
Hist -0.09
ATR (14)
0.42
12.34% of price
Realised vol 30D
111.4%
Annualised
Bollinger upper
4.47
20, 2σ
Bollinger lower
3.07
20, 2σ
50 / 200 cross
Death
3.44 vs 6.10
Trend bias
Below 200
-44.44%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.26
More volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
111.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-89.0%
Peak to trough
Max drawdown 5Y
-98.8%
Peak to trough
ATR 14
0.42
12.34% of price
Beta (reported)
0.76
5Y monthly, from filing
Short interest
Shares short
52.24K
Prior 2.19K
Change vs prior
+2,285.3%
Shorts adding
% of float
3.47%
Normal
% of shares out
2.76%
Against total outstanding
Days to cover
0.1
Liquid
Float
869.60K
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 6, 26 | D. Boral Capital | DOWNGRADE | Buy | Hold |
| Nov 28, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Oct 20, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Sep 16, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Aug 21, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 20, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| May 30, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| May 28, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Mar 27, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Feb 12, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Feb 4, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Nov 29, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateNov 21, 2016
Last split1:10
Split dateSep 4, 2026
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-10-06
Corporate Changes & Voting Matters
6-K · 2026-09-30
Corporate Changes & Voting Matters
6-K · 2026-09-24
Corporate Changes & Voting Matters
6-K · 2026-09-22
Corporate Changes & Voting Matters
6-K · 2026-09-18
Corporate Changes & Voting Matters
6-K · 2026-09-04
Corporate Changes & Voting Matters
6-K · 2026-09-03
Corporate Changes & Voting Matters
6-K · 2026-09-01
Headlines
LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
PR Newswire · 1d ago
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
PR Newswire · 7d ago
LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads
PR Newswire · 13d ago
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire · 15d ago
CollPlant to Host LightSolver Investor Webinar on September 17, 2026
PR Newswire · 27d ago
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION
PR Newswire · 33d ago
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR
PR Newswire · 34d ago
CollPlant to Implement 1-for-10 Reverse Stock Split
MT Newswires · 36d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.